BTBin Tang

Bin Tang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Bin Tang has a total of 72 co-authors. Here are the top co-authors by number of shared publications:

  • Lucia Clara Orlandini

    Department of Radiation Oncology, Presicion Radiation in Oncology Key Laboratory of Sichuan Province, Sichuan Cancer Hospital & Institute, University of Electronic Science and Technology of China, Chengdu, China

    7 shared publications
  • Jie Li

    Department of Radiation Oncology, Precision Radiation in Oncology Key Laboratory of Sichuan Province, Sichuan Cancer Hospital & Institute, University of Electronic Science and Technology of China, Chengdu, China

    6 shared publications
  • Jie Li

    Radiation Oncology Department, Sichuan Cancer Hospital & Institute, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China

    5 shared publications
  • Xianliang Wang

    Department of Radiation Oncology, Precision Radiation in Oncology Key Laboratory of Sichuan Province, Sichuan Cancer Hospital & Institute, University of Electronic Science and Technology of China, Chengdu, China

    5 shared publications
  • Feng Yang

    Department of Radiation Oncology, Precision Radiation in Oncology Key Laboratory of Sichuan Province, Sichuan Cancer Hospital & Institute, University of Electronic Science and Technology of China, Chengdu, China

    4 shared publications
  • Junxiang Wu

    Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China

    3 shared publications

Latest Publications

  • Open Access

    Integrating functional brain regions into treatment optimization: a multi-institutional dosimetric study in CyberKnife SRT for brain metastases

    by Feng Yang, Tiziana Malatesta, Lucia Clara Orlandini, Federica Murtas, Gang Yin, Bin Tang, Peng Xu, Xiongfei Liao, Xianliang Wang, Jie Li, et al.

  • Open Access

    THGEM-Based Air Ionization Chamber for Online Dose Monitoring in Conventional and FLASH Radiotherapy

    by Tianli Qiu, Feng Yang, Yi Peng, Wan Luo, JunXiang Wu, Bin Tang, Ke Wu, Herun Yang, Peng Ma, Zhiguo Xu, et al.


  • Open Access

    Step-by-step assessment of MRI-only workflow in pelvic radiotherapy: feasibility and practical implementation

    by Xin Xin, Min Liu, Jie Li, Xianliang Wang, Qingxian Zhang, Fan Wu, Bin Tang, Vincenzo Valentini, Luca Boldrini, Lucia Clara Orlandini

    Purpose Magnetic resonance imaging-only (MRI-only) radiotherapy workflow capitalizes on the superior soft tissue contrast of MRI while eliminating computed tomography-MRI (CT-MRI) registration uncertainties. Most existing studies focus on optimizing individual components of this workflow, i.e., synthetic CT (sCT) generation, dose calculation accuracy, and the reliability of MRI-based patient positioning, while often neglecting comprehensive evaluation of the whole clinical process and its interdependent technical requirements. Methods A total of 55 pelvic cancer patients, who underwent the standard radiotherapy workflow based on CT-MRI co-registration and involving a variety of imaging scanners, treatment planning systems (TPSs), and linear accelerators (LINACs), were included. For each patient, a fully integrated MRI-only approach was developed through a step-by-step evaluation of the different radiotherapy phases, including MRI-alone delineation, sCT generation with dose calculation, and cone beam CT-MRI (CBCT-MRI)-guided positioning. Comparative evaluations with the standard workflow were performed for target segmentation (dice similarity coefficient [DSC] and Hausdorff distance [HD]), dose calculation (DVH parameters and gamma analysis), and daily patient positioning (CBCT-CT versus CBCT-MRI registrations). Results The proposed MRI-only workflow is applicable throughout all radiotherapy phases and compatible across multiple imaging systems, treatment planning systems, and linear accelerators. MRI-only delineation showed excellent agreement for the prostate (DSC = 0.948 ± 0.028) and cervix (DSC = 0.940 ± 0.015), whereas contour agreement for the rectum and prostate bed (DSC = 0.696 ± 0.037 and 0.689 ± 0.047, respectively) fell within the range of inter-observer variability. Dosimetric comparisons revealed no significant differences between CT- and sCT-based plans (p > 0.05), with median gamma pass rates of 99.0% and 97.9% for the whole body using 3%/3 mm and 2%/2 mm criteria, respectively. CBCT-MRI registration indicated positioning errors comparable to CBCT-CT. Conclusion MRI-only pelvic radiotherapy workflows are clinically feasible through customized protocols for target and OAR segmentation, MRI scanner setup and immobilization, sequence selection, sCT-based dose calculation validation, and CBCT-MRI matching reliability.


  • Open Access

    Reproducibility and stability of voluntary deep inspiration breath hold and free breath in breast radiotherapy based on real-time 3-dimensional optical surface imaging system

    by Junxiang Wu, Feng Yang, Jie Li, Xianliang Wang, Ke Yuan, Lipeng Xu, Fan Wu, Bin Tang, Lucia Clara Orlandini

    The aim of this study was to evaluate the inter-fraction reproducibility and intra-fraction stability of breast radiotherapy using voluntary deep-inspiration breath hold (DIBH) and free breathing (FB) based on an optical surface imaging system (OSIS). Seventeen patients (510 breath-hold sessions) treated using a field-in-field (FiF) technique and twenty patients (600 breath-free sessions) treated with a volume-modulated arc therapy (VMAT) technique were included in this retrospective study. All the patients were positioned with the guidance of CBCT and OSIS, and also monitored with OSIS throughout the whole treatment session. Eight setup variations in three directions were extracted from the treatment reports of OSIS for all sessions and were subsequently manually introduced to treatment plans, resulting in a total of 296 perturbed plans. All perturbed plans were recalculated, and the dose volume histograms (DVH) for the target and organs at risk (OAR) were analyzed. The OSIS and CBCT for both DIBH and FB treatments showed a good agreement of less than 0.30 cm in each direction. The intra-fraction respiratory motion data during DIBH were −0.06 ± 0.07 cm, 0.12 ± 0.15 cm, and 0.12 ± 0.12 cm in the lateral, longitudinal, and vertical directions, respectively; for FB, the respiratory motion data were −0.02 ± 0.12 cm, 0.08 ± 0.18 cm, and 0.14 ± 0.20 cm, respectively. For the target, DIBH plans were more sensitive to setup errors; the mean deviations in D95 for CTV were 39.78 Gy–40.17 Gy for DIBH and 38.46 Gy–40.52 Gy for FB, respectively. For the OARs, the mean deviations of V10, V20, and Dmean to the heart; V5, V20, and Dmean to the ipsilateral lung; and Dmean to the breast were lower for the FB plan compared with the DIBH plan. Based on OSIS, our results indicate that both DIBH and FB can provide good reproducibility in the inter-fractions and stability in the intra-fractions. When the patient respiratory motion is large, the FB technology has greater possibility for the undercoverage of the target volume, while DIBH technology is more likely to result in increases in dose to OARs (the lung, heart, and contralateral breast).


  • Open Access

    Dose tracking assessment for magnetic resonance guided adaptive radiotherapy of rectal cancers

    by Xin Xin, Bin Tang, Fan Wu, Jinyi Lang, Jie Li, Xianliang Wang, Min Liu, Qingxian Zhang, Xiongfei Liao, Feng Yang, et al.

    Magnetic resonance-guided adaptive radiotherapy (MRgART) at MR-Linac allows for plan optimisation on the MR-based synthetic CT (sCT) images, adjusting the target and organs at risk according to the patient’s daily anatomy. Conversely, conventional linac image-guided radiotherapy (IGRT) involves rigid realignment of regions of interest to the daily anatomy, followed by the delivery of the reference computed tomography (CT) plan. This study aims to evaluate the effectiveness of MRgART versus IGRT for rectal cancer patients undergoing short-course radiotherapy, while also assessing the dose accumulation process to support the findings and determine its usefulness in enhancing treatment accuracy. Nineteen rectal cancer patients treated with a 1.5 Tesla MR-Linac with a prescription dose of 25 Gy (5 Gy x 5) and undergoing daily adapted radiotherapy by plan optimization based on online MR-based sCT images, were included in this retrospective study. For each adapted plan ( $$\:{\text{T}\text{P}}_{\text{a}\text{d}\text{a}\text{p}}$$ ), a second plan ( $$\:{\text{T}\text{P}}_{\text{I}\text{G}\text{R}\text{T}}$$ ) was generated by recalculating the reference CT plan on the daily MR-based sCT images after rigid registration with the reference CT images to simulate the IGRT workflow. Dosimetry of $$\:{\text{T}\text{P}}_{\text{a}\text{d}\text{a}\text{p}}$$ and $$\:\:{\text{T}\text{P}}_{\text{I}\text{G}\text{R}\text{T}}$$ was compared for each fraction. Cumulative doses on the first and last fractions were evaluated for both workflows. The dosimetry per single fraction and the cumulative doses were compared using dose-volume histogram parameters. Ninety-five fractions delivered with MRgART were compared to corresponding simulated IGRT fractions. All MRgART fractions fulfilled the target clinical requirements. IGRT treatments did not meet the expected target coverage for 63 out of 94 fractions (67.0%), with 13 fractions showing a V95 median point percentage decrease of 2.78% (range, 1.65-4.16%), and 55 fractions exceeding the V107% threshold with a median value of 15.4 cc (range, 6.0-43.8 cc). For the bladder, the median $$\:{\text{D}}_{15\text{c}\text{c}}$$ values were 18.18 Gy for the adaptive fractions and 19.60 Gy for the IGRT fractions. Similarly the median $$\:{\text{D}}_{5\text{c}\text{c}}$$ values for the small bowel were 23.40 Gy and 25.69 Gy, respectively. No statistically significant differences were observed in the doses accumulated on the first or last fraction for the adaptive workflow, with results consistent with the single adaptive fractions. In contrast, accumulated doses in the IGRT workflow showed significant variations mitigating the high dose constraint, nevertheless, more than half of the patients still did not meet clinical requirements. MRgART for short-course rectal cancer treatments ensures that the dose delivered matches each fraction of the planned dose and the results are confirmed by the dose accumulation process, which therefore seems redundant. In contrast, IGRT may lead to target dose discrepancies and non-compliance with organs at risk constraints and dose accumulation can still highlight notable dosimetric differences.


  • Open Access

    Potential dosimetric error in the adaptive workflow of a 1.5 T MR-Linac from patient movement relative to immobilisation systems

    by Min Liu, Bin Tang, Lucia Clara Orlandini, Jie Li, Xianliang Wang, Qian Peng, David Thwaites

    In magnetic resonance- (MR-) based adaptive workflows for an MR-linac, the treatment plan is optimized and recalculated online using the daily MR images. The Unity MR-linac is supplied with a patient positioning device (ppd) using pelvic and abdomen thermoplastic masks attached to a board with high-density components. This study highlights the dosimetric effect of using this in such workflows when there are relative patient-ppd displacements, as these are not visualized on MR imaging and the treatment planning system assumes the patient is fixed relative to the ppd. The online adapted plans of two example rectum cancer patients treated at a Unity MR-linac were perturbed by introducing relative patient-ppd displacements, and the effect was evaluated on plan dosimetry. Forty-eight perturbed clinical adapted plans were recalculated, based on online MR-based synthetic computed tomography, and compared with the original plans, using dose-volume histogram parameters and gamma analysis. The target volume covered by the prescribed dose ( $${\text{D}}_{\text{p}\text{r}\text{e}}$$ D pre ) and by at least 107% of $${\text{D}}_{\text{p}\text{r}\text{e}}$$ D pre varied up to − 1.87% and + 3.67%, respectively for 0.5 cm displacements, and to − 3.18% and + 4.96% for 2 cm displacements; whilst 2%–2 mm gamma analysis showed a median value of 92.9%. The use of a patient positioning system with high-density components in a Unity MR-based online adaptive treatment workflow can introduce unrecognized errors in plan dosimetry and it is recommended not to use such a device for such treatments, without modifying the device and the workflow, followed by careful clinical evaluation, or alternatively to use other immobilization methods.


  • Open Access

    Feasibility of delta radiomics–based pCR prediction for rectal cancer patients treated with magnetic resonance–guided adaptive radiotherapy

    by Junxiang Wu, Juan Xiao, Yihong Li, Fan Wu, Qian Peng, Churong Li, Bin Tang, Lucia Clara Orlandini

    Magnetic resonance–guided adaptive radiotherapy (MRgART) represents the latest frontier in precision radiotherapy. It is distinguished from other modalities by the possibility of acquiring high-contrast soft tissue images, combined with the ability to recalculate and re-optimize the plan on the daily anatomy. The extensive database of available images offers ample scope for using disciplines such as radiomics to try to correlate features and outcomes. This study aimed to correlate the change of radiomics feature along the treatment to pathological complete response (pCR) for locally advanced rectal cancer (LARC) patients. Twenty-eight LARC patients undergoing neoadjuvant chemoradiotherapy (nCRT) with a short course (25 Gy, 5 Gy × 5f) MRgART at 1.5 Tesla MR-Linac were enrolled. The T2-weighted images acquired at each fraction, corresponding target delineation, pCR result of the surgical specimen, and clinical variables were collected. Seven families of features [First Order, Shape, Gray-level Co-occurrence Matrix (GLCM), Gray-level Dependence Matrix (GLDM), Gray-level Run Length Matrix (GLRLM), Gray-level Size Zone Matrix (GLSZM), and Neighborhood Gray Tone Difference Matrix (NGTDM)] were extracted, and delta features were calculated from the ratio of features of each successive fraction to those of the first fraction. Mann-Whitney U test and LASSO were utilized to reduce the dimension of features and select those features that are most significant to pCR. At last, the radiomics signatures were established by linear regression with the final set of features and their coefficients. A total of 581 radiomics features were extracted, and 2,324 delta features were calculated for each patient. Nineteen features and delta features, and one clinical variable (cN) were significant (p< 0.05) to pCR; seven predictive features were further selected and included in the linear regression to construct the radiomics signature significantly discriminating pCR and non-pCR groups (p< 0.05). Delta features based on MRI images acquired during a short course MRgART could potentially be used to predict treatment response in LARC patients undergoing nCRT.


  • Open Access

    Effectiveness of bladder filling control during online MR-guided adaptive radiotherapy for rectal cancer

    by Xi Feng, Bin Tang, Xinghong Yao, Min Liu, Xiongfei Liao, Ke Yuan, Qian Peng, Lucia Clara Orlandini

    Background: Magnetic resonance-guided adaptive radiotherapy (MRgART) treatment sessions at MR-Linac are time-consuming and changes in organs at risk volumes can impact the treatment dosimetry. This study aims to evaluate the feasibility to control bladder filling during the rectum MRgART online session and its effectiveness on plan dosimetry. Methods: A total of 109 online adaptive sessions of 24 rectum cancer patients treated at Unity 1.5 T MR-Linac with a short course radiotherapy (25 Gy, 5 Gy × 5) for whom the adaptive plan was optimized and recalculated online based on the daily magnetic resonance imaging (MRI) were analysed. Patients were fitted with a bladder catheter to control bladder filling; the bladder is emptied and then partially filled with a known amount of saline at the beginning and end of the online session. A first MRI ( $${\mathrm{MRI}}_{\mathrm{i}}$$ MRI i ) acquired at the beginning of the session was used for plan adaptation and the second ( $${\mathrm{MRI}}_{\mathrm{f}}$$ MRI f ) was acquired while approving the adapted plan and rigidly registered with the first to ensure the appropriateness of the isodoses on the ongoing delivery treatment. For each fraction, the time interval between the two MRIs and potential bladder changes were assessed with independent metrics, and the impact on the plan dosimetry was evaluated by comparing target and organs at risk dose volume histogram cut-off points of the plan adapted on $${\mathrm{MRI}}_{\mathrm{i}}$$ MRI i and recalculated on $${\mathrm{MRI}}_{\mathrm{f}}$$ MRI f . Results: Median bladder volume variations, DSC, and HD of 8.17%, 0.922, and 2.92 mm were registered within a median time of 38 min between $${\mathrm{MRI}}_{\mathrm{i}}$$ MRI i and $${\mathrm{MRI}}_{\mathrm{f}}$$ MRI f ; dosimetric differences < 0.65% were registered for target coverage, and < 0.5% for bladder, small bowel and femoral heads constraints, with a p value > 0.05. Conclusion: The use of a bladder filling control procedure can help ensure the dosimetric accuracy of the online adapted treatment delivered.


  • Open Access

    Role of MRI‑based radiomics in locally advanced rectal cancer (Review)

    by Siyu Zhang, Mingrong Yu, Dan Chen, Peidong Li, Bin Tang, Jie Li

    Colorectal cancer is the third most common type of cancer, with high morbidity and mortality rates. In particular, locally advanced rectal cancer (LARC) is difficult to treat and has a high recurrence rate. Neoadjuvant chemoradiotherapy (NCRT) is one of the standard treatment programs of LARC. If the response to treatment and prognosis in patients with LARC can be predicted, it will guide clinical decision‑making. Radiomics is characterized by the extraction of high‑dimensional quantitative features from medical imaging data, followed by data analysis and model construction, which can be used for tumor diagnosis, staging, prediction of treatment response and prognosis. In recent years, a number of studies have assessed the role of radiomics in NCRT for LARC. MRI‑based radiomics provides valuable data and is expected to become an imaging biomarker for predicting treatment response and prognosis. The potential of radiomics to guide personalized medicine is widely recognized; however, current limitations and challenges prevent its application to clinical decision‑making. The present review summarizes the applications, limitations and prospects of MRI‑based radiomics in LARC.